Evidence for coupling between steady-state and dynamic extracellular dopamine concentrations in the rat striatum

Journal of Neurochemistry

Volumn 114, Issue 1, 2010, Pages 150-159

  Wang, Yuexiang ^a   Moquin, Keith F ^a   Michael, Adrian C ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Autoinhibtion; Dopamine; Dynamics; Kynurenate; Striatum; Voltammetry

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; KYNURENIC ACID; QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; CELL HETEROGENEITY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ELECTROSTIMULATION; MALE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; RAT;

ANIMALS; CORPUS STRIATUM; DOPAMINE; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; KYNURENIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 77953303442     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06740.x     Document Type: Article

References (57)

1. Abercrombie E. D., Bonatz A. E. Zigmond M. J. (1990) Effects of l-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 36 44.
2. Amori L., Wu H. Q., Marinozzi M., Pellicciari R., Guidetti P. Schwarcz R. (2009) Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience 159, 196 203.
3. Antonini A. Barone P. (2008) Dopamine agonist-based strategies in the treatment of Parkinson's disease. Neurol Sci 29 (Suppl. 5 S371 S374.
4. 2 underlies glutamate-dependent inhibition of striatal dopamine release. Proc. Natl Acad. Sci. USA 100, 11729 11734.
5. Benoit-Marand M., Borrelli E. Gonon F. (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J. Neurosci. 21, 9134 9141.
6. Birkmayer W. Hornykiewicz O. (1998) The effect of l-3,4- dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism Relat. Disord. 4, 59 60.
7. Booij J., Tissingh G., Winogrodzka A. van Royen E. A. (1999) Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism. Eur. J. Nucl. Med. 26, 171 182.
8. Borland L. M. Michael A. C. (2004) Voltammetric study of the control of striatal dopamine release by glutamate. J. Neurochem. 91, 220 229.
9. 2 is a novel, endogenous modulator of synaptic dopamine release. J. Neurophysiol. 85, 2468 2476.
10. Cowell R. M., Kantor L., Hewlett G. H., Frey K. A. Gnegy M. E. (2000) Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes. Eur. J. Pharmacol. 389, 59 65.
11. Dagher A. Robbins T. W. (2009) Personality, addiction, dopamine: insights from Parkinson's disease. Neuron 61, 502 510.
12. Ewing A. G., Bigelow J. C. Wightman R. M. (1983) Direct in vivo monitoring of dopamine released from two striatal compartments in the rat. Science 221, 169 171.
13. Garris P. A. Wightman R. M. (1995) Regional differences in dopamine release, uptake, and diffusion measured by fast-scan cyclic voltammetry, in Neuromethods Vol 27: Voltammertic Methods in Brain Systems (Boulton A., Baker G. Adams R. N., eds pp. 179 220. Humana Press
14. Garris P. A., Ciolkowski E. L., Pastore P. Wightman R. M. (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J. Neurosci. 14, 6084 6093.
15. Heien M. L. A. V., Khan A. S., Ariansen J. L., Cheer J. F., Phillips P. E. M., Wassum K. M. Wightman R. M. (2005) Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc. Natl Acad. Sci. USA 102, 10023 10028.
16. Hernandez L., Rossell S., Tucci S., Paredes D. Rada P. (2007) Improvement of the temporal resolution of brain microdialysis: sampling in seconds, in Handbook of Behavioral Neuroscience, Vol 16: Handbook of Microdialysis Methods, Applications and Clinical Aspects (Westerink B. H. C. Cremers T. I. F. H., eds pp. 267 277. Academic Press
17. Hilmas C., Pereira E. F., Alkondon M., Rassoulpour A., Schwarcz R. Albuquerque E. X. (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J. Neurosci. 21, 7463 7473.
18. Hornykiewicz O. (2002) l-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids 23, 65 70.
19. Kennedy R. T., Jones S. R. Wightman R. M. (1992) Dynamic observation of dopamine autoreceptor effects in rat striatal slices. J. Neurochem. 59, 449 455.
20. Kirchhoff J., Mork A., Brennum L. T. Sager T. N. (2009) Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice. Neuroreport 20, 482 486.
21. Kita J. M., Parker L. E., Phillips P. E. M., Garris P. A. Wightman R. M. (2007) Paradoxical modulation of short-term facilitation of dopamine release by dopamine autoreceptors. J. Neurochem. 102, 1115 1124.
22. Koob G. F. Bloom F. E. (1988) Cellular and molecular mechanisms of drug dependence. Science 242, 715 723.
23. Kuhr W. G., Ewing A. G., Caudill W. L. Wightman R. M. (1984) Monitoring the stimulated release of dopamine with in vivo voltammetry. I: characterization of the response observed in the caudate nucleus of the rat. J. Neurochem. 43, 560 569.
24. Kuhr W. G., Wightman R. M. Rebec G. V. (1987) Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle. Brain Res. 418, 122 128.
25. Kulagina N. V., Zigmond M. J. Michael A. C. (2001) Glutamate regulates the spontaneous and evoked release of dopamine in the rat striatum. Neuroscience 102, 121 128.
26. Levy F. Swanson J. M. (2001) Timing, space and ADHD: the dopamine theory revisited. Aust. N. Z. J. Psychiatry 35, 504 511.
27. Limberger N., Trout S. J., Kruk Z. L. Starke K. (1991) "Real time" measurement of endogenous dopamine release during short trains of pulses in slices of rat neostriatum and nucleus accumbens: role of autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 344, 623 629.
28. Lonart G. Zigmond M. J. (1991) High glutamate concentrations evoke Ca(++)-independent dopamine release from striatal slices: a possible role of reverse dopamine transport. J. Pharmacol. Exp. Ther. 256, 1132 1138.
29. Maneuf Y. P., Crossman A. R. Brotchie J. M. (1997) The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease. Exp. Neurol. 148, 265 270.
30. May L. J. Wightman R. M. (1989a) Effects of D-2 antagonists on frequency-dependent stimulated dopamine overflow in nucleus accumbens and caudate-putamen. J. Neurochem. 53, 898 906.
31. May L. J. Wightman R. M. (1989b) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res. 487, 311 320.
32. Mitala C. M., Wang Y., Borland L. M., Jung M., Shand S., Watkins S., Weber S. G. Michael A. C. (2008) Impact of microdialysis probes on vasculature and dopamine in the rat striatum: a combined fluorescence and voltammetric study. J. Neurosci. Methods 174, 177 185.
33. Miyazaki I. Asanuma M. (2008) Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med. Okayama 62, 141 150.
34. Montague P. R., McClure S. M., Baldwin P. R., Phillips P. E. M., Budygin E. A., Stuber G. D., Kilpatrick M. R. Wightman R. M. (2004) Dynamic gain control of dopamine delivery in freely moving animals. J. Neurosci. 24, 1754 1759.
35. Moquin K. F. Michael A. C. (2009) Tonic autoinhibition contributes to the heterogeneity of evoked dopamine release in the rat striatum. J. Neurochem. 110, 1491 1501.
36. Murphy B. L., Arnsten A. F., Goldman-Rakic P. S. Roth R. H. (1996) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl Acad. Sci. USA 93, 1325 1329.
37. Nagatsua T. Sawadab M. (2009) l-dopa therapy for Parkinson's disease: past, present, and future. Parkinsonism Relat. Disord. 15 (Suppl. 1 S3 S8.
38. Nandi P. Lunte S. M. (2009) Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal. Chim. Acta 651, 1 14.
39. Pellegrino L. J., Pellegrino A. S. Cushman A. J. (1979) A stereotaxic atlas of the rat brain. Plenum Press
40. Phillips P. E. M., Hancock P. J. Stamford J. A. (2002) Time window of autoreceptor-mediated inhibition of limbic and striatal dopamine release. Synapse 44, 15 22.
41. Poeggeler B., Rassoulpour A., Wu H. Q., Guidetti P., Roberts R. C. Schwarcz R. (2007) Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-d-aspartate neurotoxicity. Neuroscience 148, 188 197.
42. Rassoulpour A., Wu H. Q., Ferre S. Schwarcz R. (2005) Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. J. Neurochem. 93, 762 765.
43. Rice M. E. Cragg S. J. (2004) Nicotine amplifies reward-related dopamine signals in striatum. Nat. Neurosci. 7, 583 584.
44. Robinson D. L. Wightman R. M. (2007) Rapid dopamine release in freely moving rats, in Frontiers in Neuroengineering: Electrochemical Methods for Neuroscience (Michael A. C. Borland L. M., eds pp. 17 34. CRC Press Taylor Francis Group
45. Schultz W. (2007) Multiple dopamine functions at different time courses. Ann. Rev. Neurosci. 30, 259 288.
46. Schwarcz R., Rassoulpour A., Wu H.-Q., Medoff D., Tamminga C. A. Roberts R. C. (2001) Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50, 521 530.
47. Schwarz J. (2003) Rationale for dopamine agonist use as monotherapy in Parkinson's disease. Curr. Opin. Neurol. 16 (Suppl. 1 S27 S33.
48. Smith A. D. Justice J. B. (1994) The effect of inhibition of synthesis, release, metabolism and uptake on the microdialysis extraction fraction of dopamine. J. Neurosci. Methods 54, 75 82.
49. Stone J. M., Morrison P. D. Pilowsky L. S. (2007) Glutamate and dopamine dysregulation in schizophrenia - a synthesis and selective review. J. Psychopharmacol. 21, 440 452.
50. Venton B. J., Zhang H., Garris P. A., Phillips P. E. M., Sulzer D. Wightman R. M. (2003) Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J. Neurochem. 87, 1284 1295.
51. Watson C. J., Venton B. J. Kennedy R. T. (2006) In vivo measurements of neurotransmitters by microdialysis sampling. Anal. Chem. 78, 1391 1399.
52. Wieczorek W. Kruk Z. L. (1995) Influences of neuronal uptake and D2 autoreceptors on regulation of extracellular dopamine in the core, shell and rostral pole of the rat nucleus accumbens. Brain Res. 699, 171 182.
53. Wightman R. M. Robinson D. L. (2002) Transient changes in mesolimbic dopamine and their association with 'reward'. J. Neurochem. 82, 721 735.
54. Wightman R. M. Zimmerman J. B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Brain Res. Rev. 15, 135 144.
55. Wightman R. M., Amatore C., Engstrom R. C., Hale P. D., Kristensen E. W., Kuhr W. G. May L. J. (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513 523.
56. Zahniser N. R., Larson G. A. Gerhardt G. A. (1999) In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors. J. Pharmacol. Exp. Ther. 289, 266 277.
57. Zhang H. Sulzer D. (2004) Frequency-dependent modulation of dopamine release by nicotine. Nat. Neurosci. 7, 581 582.